Sydney, Aug. 31, 2021 (GLOBE NEWSWIRE) -- SYDNEY, AUSTRALIA – 31 August 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) is pleased to advise its Chinese partner for eftilagimod alpha (“efti” or “IMP321”), EOC Pharma (“EOC”) is planning to expand its clinical trial pipeline for efti (designated EOC202 in China) in China.

Visit link:
Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline

Global News Feed Comments Off on Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline | September 1st, 2021

The Company’s Proposed Cannabidiol Delivery System Utilizes its Proprietary Cannabidiol (“CBD”) Infused Chewing Gum Platform

Excerpt from:
Tauriga Sciences, Inc. Initiates Clinical Trial to Examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum

Global News Feed Comments Off on Tauriga Sciences, Inc. Initiates Clinical Trial to Examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum | September 1st, 2021

ALCESTER, United Kingdom and BEVERLY, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision for more flexible and accessible dialysis care, announced today John E. Milad, Chief Executive Officer, will present at the 2021 Wells Fargo Virtual Healthcare Conference on Friday, September 10, 2021, at 9:20 a.m. Eastern Time.

Read more from the original source:
Quanta to Present at the 2021 Wells Fargo Virtual Healthcare Conference on September 10, 2021

Global News Feed Comments Off on Quanta to Present at the 2021 Wells Fargo Virtual Healthcare Conference on September 10, 2021 | September 1st, 2021

MARLBOROUGH, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

Follow this link:
Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Global News Feed Comments Off on Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference | September 1st, 2021

SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO”, “we” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the second quarter ended June 30, 2021.

More here:
ECMOHO Limited Announces Second Quarter 2021 Unaudited Financial Results

Global News Feed Comments Off on ECMOHO Limited Announces Second Quarter 2021 Unaudited Financial Results | September 1st, 2021

SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin R. Lind, Longboard’s President & Chief Executive Officer, will present virtually in a fireside chat format at two upcoming investor conferences: Citi’s 16th Annual BioPharma Virtual Conference and H.C. Wainwright’s 23rd Annual Global Investment Conference.

See the original post here:
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences

Global News Feed Comments Off on Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences | September 1st, 2021

LAS VEGAS, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched Ultimate Brain Nutrients RELIEF™, a proprietary, patent-pending natural formulation that provides relief from symptoms often associated with migraine headaches, while increasing brain and cognitive activation.

See more here:
Healthy Extracts Introduces Ultimate Brain Nutrients RELIEF™ for Migraine Sufferers, a Breakthrough Natural Treatment Clinically Shown to Reduce...

Global News Feed Comments Off on Healthy Extracts Introduces Ultimate Brain Nutrients RELIEF™ for Migraine Sufferers, a Breakthrough Natural Treatment Clinically Shown to Reduce… | September 1st, 2021

Company to present at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually September 13-15, 2021 Company to present at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually September 13-15, 2021

Go here to see the original:
Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy

Global News Feed Comments Off on Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy | September 1st, 2021

CALGARY, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE:XRX) (OTCQB:XRTXF), a biotechnology company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the addition of one new member to the Company’s clinical advisory board, Dr. Charles Edelstein.

Read this article:
XORTX Announces New Clinical Advisory Board Member

Global News Feed Comments Off on XORTX Announces New Clinical Advisory Board Member | September 1st, 2021

Company announcement – No. 54 / 2021

See the article here:
Total number of shares and voting rights in Zealand Pharma at August 31, 2021

Global News Feed Comments Off on Total number of shares and voting rights in Zealand Pharma at August 31, 2021 | September 1st, 2021

DUBLIN, Ireland and FORT WASHINGTON, Pa., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroeder, Chief Executive Officer at Nabriva, will provide a company overview and business update at the H.C. Wainwright 23rd Annual Virtual Global Investment Conference. The presentation will be available on-demand starting Monday, September 13, at 7:00 A.M. (ET).

Go here to read the rest:
Nabriva Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Global News Feed Comments Off on Nabriva Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference | September 1st, 2021

Company announcement – No. 55 / 2021

Link:
Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium

Global News Feed Comments Off on Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium | September 1st, 2021

- On Track to Report CBP-201 Phase 2B Top-Line Data Evaluating Moderate-to-Severe Atopic Dermatitis (AD) in Q4 of 2021 -

Here is the original post:
Connect Biopharma Provides Business Update and Reports First Half 2021 Financial Results

Global News Feed Comments Off on Connect Biopharma Provides Business Update and Reports First Half 2021 Financial Results | September 1st, 2021

SAN DIEGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the H.C. Wainwright 23rd Annual Global Investment Conference.

More here:
Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Global News Feed Comments Off on Histogen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference | September 1st, 2021

PLEASANTON, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

See more here:
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Global News Feed Comments Off on 10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference | September 1st, 2021

PRINCETON, N.J., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the following virtual investor conferences:

Follow this link:
Certara to Participate in Upcoming Investor Conferences

Global News Feed Comments Off on Certara to Participate in Upcoming Investor Conferences | September 1st, 2021

Basel, September 01, 2021 — Novartis has reached a commercial agreement with the NHS in England as part of a collaboration to pioneer a first-of-its-kind population health management approach to address elevated LDL-C in eligible patients with ASCVD across England.

Here is the original post:
World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio®...

Global News Feed Comments Off on World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio®… | September 1st, 2021

On August 31, 2021 JSC Olainfarm organized its Investor Conference Webinar. During the webinar J?nis Buks, the chairman of the Management Board and J?nis Leimanis, member of the Management Board analyzed the financial results of 6 months 2021 and informed about other recent activities within the company.

See the original post here:
Recording of the 6 months 2021 Investor Conference Webinar

Global News Feed Comments Off on Recording of the 6 months 2021 Investor Conference Webinar | September 1st, 2021

Stem cell characterization kitst Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations for the base year as well as in historic data analysis.

Bottom-up approach is always used to obtain Stem cell characterization kits insightful data for the specific country/regions. The country specific data is again analyzed to derive data at a global level.

Market Overview:-

Stem cells are biological cells that can be converted into specific type of cells as per the bodys requirement. Stem cells are of two types, i.e., adult stem cells and embryonic stem cells. Stem cells can be used to treat various diseases such as cancer, neurodegenerative disorder, cardiovascular disorder and tissue regeneration. Stem cell characterization is the initial step for stem cell research.

Stem cell characterization kit is required to understand the utility of the stem cells in downstream experiments and to confirm the pluripotency of the stem cell.The growth of the stem cell characterization kits market is expected to be being fuelled by government funding for stem cell research.

To Remain Ahead Of Your Competitors, Request for Brochure https://www.factmr.com/connectus/sample?flag=B&rep_id=2691

Fact.MR, a leading authority on market research brings original, in-depth, and insightful reports to investors On Stem Cell Characterization Kits Market Sales & Demand. Fact.MRs report will highlight various growth forecasts, key trends, and notable segments ripe for upcoming investments.

Key Parameters analyzed while estimating the Stem Cell Characterization Kits market include:

Overall Population by age group/Prevalence or Incidence of any disease/Treatment Seeking Rate/Dosage pattern/Average duration of treatment/Overall treatment cost and Reimbursement are considered.

Overall Population/Prevalence or Incidence of disease/treatment seeking rate/ average duration of the treatment/average number of devices used per patient / average number of procedure per device/ average selling price per device/reimbursement are considered.

Number of Healthcare facilities (Hospitals/Ambulatory Surgical Centers/Clinics etc.)

Average number of devices installed per facilities/ lifespan of the devices/replacement rate of the equipment/new sales of the equipment per year/average selling price per equipment are considered.

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts to arrive at various estimations and projections for Sales & Demand of Stem Cell Characterization Kits, its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies.

SWOT analysis has been performed in the Sales study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels

Company share analysis is used to derive the size of the global Stem Cell Characterization Kits market. As well as a study of the revenues of companies for the last several years also provides the base for forecasting the market size and its Sales growth rate.

This study offers an overview of the existing market trends, metrics, drivers, and restrictions and also offers a point of view for important segments. The report also tracks product and services demand growth forecasts for the market.

Based on type of stem cell, the stem cell characterization kits market is segmented into:

Based on application, the stem cell characterization kits market is segmented into:

Based on end user, the stem cell characterization kits market is segmented into:

North America and Europe are expected to witness significant growth in the global stem cell characterization kit market over the forecast period. This is owing to presence of key manufacturers and researchers of stem cell based therapies in these regions. Moreover, manufacturers such as ThermoFisher Scientific, and Becton Dickinson providing stem cell assays are present in North America region.

Asia Pacific is expected to show significant growth in the stem cell characterization kit market over the forecast period, as researchers from China and Japan are working on stem cell based therapies. For instance, in 2017, clinical trials of embryonic stem cells were launched in China for Parkinsons disease.

The Stem Cell Characterization Kits Sales study analyzes crucial trends that are currently determining the growth of Stem Cell Characterization Kits Market.

There is also to the study approach a detailed segmental review. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.

The Key trends Analysis of Stem Cell Characterization Kits also provides dynamics that are responsible for influencing thefuture Sales and Demand of Stem Cell Characterization Kits marketover the forecast period.

Request Customized Report as Per Your Requirementshttps://www.factmr.com/connectus/sample?flag=RC&rep_id=2691

The report covers following Stem Cell Characterization Kits Market insights and assessment that are helpful for all participants involved in the Stem Cell Characterization Kits market:

NOTE:Our team are studying Covid19 and its impact on the Sales growth of Stem Cell Characterization Kits market and where necessary we will consider the Covid-19 footmark for better analysis of the market Demand and industries outlook. Contact us cogently for more detailed information.

Further, the Stem Cell Characterization Kits market Survey report emphasizes the adoption pattern And Demand of Stem Cell Characterization Kits Market across various industries.

The Stem Cell Characterization Kits Sales study offers a comprehensive analysis on diverse features including production capacities, Stem Cell Characterization Kits demand, product developments, Stem Cell Characterization Kits revenue generation and Stem Cell Characterization Kits Market Outlook across the globe.

Competitive Landscape Analysis On Stem Cell Characterization KitsMarket:

In this report, leading market participants involved in the manufacturing of Stem Cell Characterization Kits are covered. Analysis regarding their product portfolio, key financials such as market shares and sales, SWOT analysis and key strategies are included in this report. To provide decision-makers with credible insights on their competitive landscape, the Stem Cell Characterization Kits industry research report includes detailed market competitive landscape analysis.

Some of the key participants in the global Stem Cell Characterization Kits Market include :

Examples of some of the key participants in the stem cell characterization kits market identified across the value chain include Merck KGaA, Celprogen, Inc., Creative Bioarray, Thermo Fisher Scientific Inc., BD Biosciences, R&D Systems, Inc., System Biosciences, Cosmo Bio USA, BioCat GmbH, and DS Pharma Biomedical Co., Ltd.

Enquiry Before Buying https://www.factmr.com/connectus/sample?flag=EB&rep_id=2691

After glancing through the report on globalStem Cell Characterization Kits market Demand, readers will get valuable insight into the following:

The Survey report highlights the growth factors and entry barriers for the key players and talks about the new trends emerging in the globalStem Cell Characterization Kitsmarket.

In addition to this, the study sheds light on changing market size, revenue growth, and share of important product segments. Analysts at Fact.MR give prominent data on recent technological developments and product developments in the Stem Cell Characterization Kits Demand during the assessment period.

A comprehensive estimate on Demand of Stem Cell Characterization Kits market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Stem Cell Characterization Kits market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Market Snapshot

The rising prevalence of cancer, cardiovascular disorders and neurodegenerative diseases and the role of stem cell therapy in treating these diseases is projected to drive the growth of stem cell characterization kit market.

As per the American Cancer Society, in 2017 cancer accounted around 1 out of 4 deaths in the U.S. and was the second most common cause of deaths in the U.S.

Stem cell therapy and stem cell transplant has huge potential to treat such chronic diseases, which is expected to have a positive impact on the growth of the stem cell characterization kits market.

Stem cell transplant is useful for the treatment of spinal cord injury, stroke, and Alzheimers disease, which is expected to fuel the adoption of stem cell characterization kits over the forecast period.

The Stem Cell Agency, California, is working on the development of new stem cell-based therapies for chronic diseases such as cancer and rare diseases, where stem cell characterization kits are primarily required.

Stem cell characterization kit is also required to identify the appropriate stem cells for the treatment of -Thalassemia. Due to the increasing research and study on stem cells, the stem cell characterization kit market is expected to witness significant growth over the forecast period.

The role of stem cell characterization kit is very important because if the stem cells are not characterized properly into required adult cell type, transplanted stem cells may revert back to teratomas and there is a possibility of transplant rejection. This is expected to influence the growth of the stem cell characterization kit market.

More Related Reports By Fact.MR On Healthcare Domain :

Veterinary Endodontics Market Veterinary Endodontics Market Forecast, Trend Analysis & Competition Tracking Global Review 202Artificial Eyes to 203Artificial Eyes

Hemorrhoids Treatment Device Market Hemorrhoids Treatment Devices Market Forecast, Trend, Analysis & Competition Tracking Global Market Insights 202Artificial Eyes to 203Artificial Eyes

About Fact.MR

Market research and consulting agency with a difference! Thats why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and well be an able research partner.

Contact:US Sales Office :11140 Rockville PikeSuite 400Rockville, MD 20852United StatesTel: +1 (628) 251-1583E-Mail:sales@factmr.com

Corporate Headquarter:Unit No: AU-01-H Gold Tower (AU),Plot No: JLT-PH1-I3A,Jumeirah Lakes Towers,Dubai, United Arab Emirates

Visit Our Website:https://www.factmr.com

Read the original post:
Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Deman - PharmiWeb.com

Spinal Cord Stem Cells Comments Off on Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Deman – PharmiWeb.com | September 1st, 2021

Researchers at the University Hospital Dusseldorf in Germany have grown primitive eye structures on brain organoids that they had made in their lab. The growth of eye structures in the lab mirrored the one that occurs in the embryo and will help us understand how eyes develop.

The human brain is a fascinating organ and an inspiration for omputer processor developerstoo. However, studying the human brain is not that easy. It is locked up inside the skull for its active period and available for analysis only after its stops to function. Most brain development also occurs quite early in life, leaving little scope for an investigation into its development and workings. Scientists have, therefore, turned to organoids, three-dimensional tissues that can be observed in the petri-dish, to improve our understanding of the brain.

Modern research methods allow us to extract skin or blood cells from an individual and then reprogram them into stem cells. Called induced pluripotent stem cells (iPSCs), these stem cells are capable of developing into any cell type in the body. Scientists carefully modify the nutritional medium they grow in to convert them into desired cell types, even making miniaturized brain cells, if needed.

Neuroscientist Jay Gopalakrishnan at University Hospital Dusseldorf and his team of researchers are interested in studying diseases of the eye. To understand, how these diseases occur in the first place, they need to understand the process of eye development. Other researchers had previously, used iPSCs to develop optic cups, structures that lead to the development of the retina - the light-sensitive layer of cells in the eye.

The retina plays an important role in the eye. It converts the light it receives into neural signals that it transmits to the brain using the optical nerve. The brain then analyses the signals, which in common terms is called 'sight'. Since the retina works closely with the brain, Gopalkrishnan and his team decided to grow the optic cups on brain cells, that were sourced from iPSCs.

Using samples from four iPSC donors, the team first made the brain organoids and then modified its growth media to induce the formation of optic cups.These cups on mini brains not only contained retinal cells but also developed lens and corneal tissue and demonstrated connections to the brain cells. During embryonic development, the retinal cells reach out to the brain but this was never demonstrated in the lab before, until this work.

The optic cups appeared as early as 30 days into the brain development and became distinctly visible by 50 days. The timeline of the development mimicked the one that occurs inside the human embryo. Out of the 314 brain organoids that the team made, almost 73 percent developed optic cups. The study was published in Stem Cell.

Our work highlights the remarkable ability of brain organoids to generate primitive sensory structures that are light sensitive and harbor cell types similar to those found in the body, Gopalkrishnan said in a press release. For future studies, the team wants to increase the viability of the optic cups to help them study diseases of the retina.

View post:
Lab-Grown Stem Cell 'Mini Brains' Just Developed Eyes - Interesting Engineering

Skin Stem Cells Comments Off on Lab-Grown Stem Cell ‘Mini Brains’ Just Developed Eyes – Interesting Engineering | August 19th, 2021